Investigating factors that influence prescribing of disease modifying treatments for MS
University of Manchester
About the project
We know that not everyone with relapsing MS has access to potentially beneficial disease modifying treatments (DMTs). In fact, prescribing of DMTs in the UK is much lower than a lot of European countries. We've also found that access to treatment varies from region to region within the UK through our Treat Me Right campaign.
Our researchers are working to understand what factors affect prescribing of DMTs in the UK. They will do this by interviewing neurologists as well as MS specialist nurses. They will then launch a UK-wide survey to investigate the different attitudes to prescribing.
How will it help people with MS?
We will use this research to campaign for policy and service changes that address the most commonly reported barriers to prescribing of DMTs. This will could result in improved access to DMTs across the whole of the UK.
The difference you can make
It is only with support like yours we can fund projects like this and help people with MS have the best possible experience with their healthcare professionals.
Make a donation to help stop MS
The next research breakthrough is in reach. Your donation will help stop MS.
£10could buy vital lab supplies for MS researchers, helping them find ways to stop MS faster
£20could pay for lab equipment like petri dishes to grow bacteria important for studying the genetics of MS
£30could process one blood sample, giving us crucial information about genes that could lead to treatment breakthroughs
Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.
£10a month could pay for lab equipment like microscope slides to study the building blocks of MS
£20a month could pay for lab equipment like petri dishes to grow bacteria important for studying genetics
£30a month could process a blood sample to help us understand what causes MS, so we can stop it in its tracks
Your regular donation means we can keep funding world class MS research with confidence. Together we will stop MS.